Tumor Ablation Market by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation and High Intensity Focused Ultrasound), Mode of Treatment (Surgical Ablation, Lararscopic Ablation and Percutaneous Ablation), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, Breast Cancer and Prostate Cancer), End users (Hospitals and Clinics) - Analysis & Forecast 2019-2030.

Report ID : 99  |  Published Date : May 2019  |  Pages : 150  |  Region : Global  |  Report Code : MD-51




Tumor Ablation Market Overviews and Introduction

The Tumor Ablation Market is estimated to be over US$ 370 Million in 2018. It is anticipated to grow in double digit during the forecast period, 2019 to 2030.

Tumor ablation is a minimally invasive technique commonly used in the treatment of tumors of the liver, kidney, lung and bones. The treatment procedure involves use of probes to burn or freeze cancer cells at the site of tumor. It is used as an option by the people for whom chemotherapy fails or who cannot undergo surgery. It is also used as a first line treatment in patients who have smaller tumors such as small hepatocellular carcinomas or benign tumor in liver.

This market is driven by increase in number of cancer cases and also by technological advancements in the ablation devices. In addition, increasing healthcare awareness, growing support from the government and the surging awareness regarding side effects of drugs are expected to drive the growth of tumor ablation market. However, strict regulatory requirements and the long approval time for the product launches are some of the factors, restraining the growth of this market to a certain extent.   

Tumor Ablation Market by Technology

On the basis of the technology, this market is segmented into radiofrequency ablation, microwave ablation, cryoablation and high intensity focused ultrasound (HIFU). Radiofrequency ablation is estimated to account for the largest share of this market. 

Tumor Ablation Market by Mode of Treatment

On the basis of mode of treatment, the market can be segmented into surgical ablation, laparoscopic ablation and percutaneous ablation. Surgical ablation accounted for largest share of the market owing to, rising prevalence of breast and liver cancer patients, which require open surgical procedures.

Tumor Ablation Market by Application

On the basis of application, the market can be segmented by lung cancer, liver cancer, kidney cancer, bone metastasis, breast cancer, prostate cancer and other cancers.  Liver cancer segment is expected to account for the largest share of this market. Lung cancer market is expected to register highest CAGR during the forecast period owing to, growing number of lung cancer cases.

Tumor Ablation Market by End User

On the basis of end user, the market can be segmented into hospitals and cancer specialty clinics. Cancer specialty clinics are expected to account for largest share of the tumor ablation market owing to preference for cancer specialty clinics.

Tumor Ablation Market by Region

On the basis of geographical distribution, the tumor ablation market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW).  North America is leading this market, owing to increasing demand for minimal invasive surgeries and increase in prevalence of cancer specially breast cancer. Asia-Pacific is likely to register fastest growth in CAGR during the forecast period, owing to presence of higher number of patients, increasing prevalence of cancer and government support in the region.

Tumor Ablation Market Prominent Players

The prominent players in the tumor ablation market are. AngioDynamics, Medtronic, Boston Scientific Corporation, NeuWave Medical, Inc., HealthTronics, Inc., Galil Medical Inc., Misonix, Sonacare Medical, MERMAID MEDICAL A/S and Integra LifeSciences Corporation among others.

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1.  Market Classification
      2.  Geographic Scope
      3.  Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
    3. Currency Used
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1.  Secondary Sources
      2.  Primary Sources
    4. Market Estimation Methodology
      1.  Bottoms Up Approach
      2.  Top Down Approach
    5. Data Validation and Triangulation
      1.  Market Forecasting Model
      2.  Limitations/Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Epidemiological Assessment
    2. Technological Advancements
    3. Application Horizon Assessment
  6.  TUMOR ABLATION MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY
    1. Radiofrequency Ablation
    2. Microwave Ablation
    3. Cryoablation
    4. High Intensity Focused Ultrasound (HIFU)
    5. Other Technologies
  7.  TUMOR ABLATION MARKET - ANALYSIS & FORECAST, BY MODE OF TREATMENT  
    1. Surgical Ablation
    2. Laparoscopic Ablation
    3. Percutaneous Ablation
  8.  TUMOR ABLATION MARKET - ANALYSIS & FORECAST, BY APPLCIATION  
    1. Liver Cancer
    2. Lung Cancer
    3. Kidney Cancer
    4. Bone Metastasis
    5. Breast Cancer
    6. Prostate Cancer
    7. Other Cancer
  9.  TUMOR ABLATION MARKET - ANALYSIS & FORECAST, BY END USERS   
    1. Hospitals
    2. Cancer Specialty Centers
  10.  TUMOR ABLATION MARKET - ANALYSIS & FORECAST, BY REGION
    1.   North America Tumor Ablation Market
      1.  North America Market, By Country
        1.  US
        2.  Canada
      2. North America Market Analysis & Forecast, By Technology
      3. North America Market Analysis & Forecast, By Mode of treatment
      4. North America Market Analysis & Forecast, By Application
      5. North America Market Analysis & Forecast, By End User
    2. Europe Tumor Ablation Market
      1. Europe Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Market Analysis & Forecast, By Technology
      3. Europe Market Analysis & Forecast, By Mode of treatment
      4. Europe Market Analysis & Forecast, By Application
      5. Europe Market Analysis & Forecast, By End User
    3. Asia Pacific Tumor Ablation Market
      1. Asia Pacific Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Market Analysis & Forecast, By Technology
      3. Asia Pacific Market Analysis & Forecast, By Mode of treatment
      4. Asia Pacific Market Analysis & Forecast, By Application
      5. Asia Pacific Market Analysis & Forecast, By End User
    4.   Rest of the World (ROW) Tumor Ablation Market
      1. Rest of the World Market, By Country/ Region
        1.  Latin America
        2.  Middle East & Africa
      2. Rest of the World Market Analysis & Forecast, By Technology
      3. Rest of the World Market Analysis & Forecast, By Mode of treatment
      4. Rest of the World Market Analysis & Forecast, By Application
      5. Rest of the World Market Analysis & Forecast, By End User
  11. COMPETETIVE LANDSCAPE
    1. Key Players & Their Competitive Positioning  (2018)
    2. Key Strategies Assessment
      1. New Technology Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Expansions
      5. Other Strategies
  12. COMPANY PROFILES (Business Overview, Technology’s Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, )*
    1.    AngioDynamics
    2.    Medtronic
    3.    Boston Scientific Corporation
    4.    NeuWave Medical, Inc.
    5.    HealthTronics, Inc.
    6.    Galil Medical Inc.
    7.    Misonix
    8.    Sonacare Medical
    9.    MERMAID MEDICAL A/S
    10. Integra LifeSciences Corporation

*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain